Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 5-Year Yield-on-Cost % is 0.04 as of Jul. 16, 2026, which is 73% below its 10-year median of 0.15. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 325 Medical Devices & Instruments companies, KMS Medisurgi ranks worse than 99.08% on this metric.
KMS Medisurgi's yield on cost for the quarter that ended in Mar. 2026 was 0.04.
The historical rank and industry rank for KMS Medisurgi's 5-Year Yield-on-Cost % or its related term are showing as below:
BOM:540468'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.04 Med: 0.15 Max: 0.17
Current: 0.04
During the past 13 years, KMS Medisurgi's highest Yield on Cost was 0.17. The lowest was 0.04. And the median was 0.15.
BOM:540468's 5-Year Yield-on-Cost % is ranked worse than 99.08% of 325
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs BOM:540468: 0.04
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
KMS Medisurgi 5-Year Yield-on-Cost % Related Terms
BOM:540468 vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of KMS Medisurgi is calculated as
KMS Medisurgi (BOM:540468) has a 5-Year Yield-on-Cost % of 0.04 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on KMS Medisurgi and its competitors. This is 73% below median its historical median of 0.15. Over the past decade, KMS Medisurgi's 5-Year Yield-on-Cost % has ranged from 0.04 to 0.17. According to the industry distribution chart, KMS Medisurgi ranks #322 out of 325 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is KMS Medisurgi's 5-Year Yield-on-Cost % too high?
KMS Medisurgi's current 5-Year Yield-on-Cost % of 0.04 is 73% below median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.17. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.31. KMS Medisurgi's value of 0.04 is 98.3% below this industry median. Based on the distribution chart, KMS Medisurgi ranks #322 out of 325 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #322 out of 325 companies for 5-Year Yield-on-Cost %. This places KMS Medisurgi in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. KMS Medisurgi's value of 0.04 is 98.3% below this benchmark. Historically, KMS Medisurgi's own 5-Year Yield-on-Cost % has ranged from 0.04 to 0.17 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 2.31, KMS Medisurgi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current 5-Year Yield-on-Cost % of 0.04 is 98.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current 5-Year Yield-on-Cost % is 0.04, which is 73% below median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.04, which is 73% below median its 10-year median of 0.15 and 98.3% below the Medical Devices & Instruments industry median of 2.31. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current 5-Year Yield-on-Cost % is 0.04 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50.
GuruFocus considers KMS Medisurgi to be Modestly Overvalued.
Key valuation signals for BOM:540468:
5-Year Yield-on-Cost %: 0.04 (73% below median its 10-year median of 0.15)
GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 98.3% below the Medical Devices & Instruments median (#322 of 325)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
